The cluster of New Medical Technologies NTMed was created. It was joined by 15 entities from the area of ​​medical devices, pharmacy and biotechnology. The agreements were signed at the CEZAMAT Center for Advanced Materials and Technologies of the Warsaw University of Technology during the “Innovations for Health” conference held there.

Joining the NTMed cluster gives the opportunity to develop innovative solutions in the field of medicine and pharmacy thanks to the cooperation of enterprises, the Warsaw University of Technology and the research center, CEZAMAT WUT.

– The level of innovation in health in Poland can compete with some of the solutions that are being developed in the United States or European Union countries – said Mariusz Wielec, Director of CEZAMAT WUT, during the ceremony of signing the agreements. “I believe we are on an upward curve when it comes to innovation in both medical devices and medicines,” he added.

Industries that create solutions for healthcare are at the forefront when it comes to the development of innovation in Poland. The launch of the NTMed cluster aims to intensify the cooperation of all entities associated in it.

– It is also important to achieve a critical mass that will allow us to talk seriously with institutions that have funds allocated for innovation, as well as, for example, to stay in dialogue with regulators – explained director Wielec.

Conference participants pointed out that we are dealing with two groups of innovative solutions. The first concerns medical technologies in which the financial threshold for entering the market is relatively lower. The second one – the pharmaceutical sector, in which it takes up to 12 years – as indicated by Marta Winiarska, President of the Polish Association of Innovative Medical Biotechnology Companies BioInMed – for a new drug to be developed. In both, it is necessary to obtain funds for their development and introduction to the market, and this cannot be done without the support of state funds, because business is not able to bear the research risk on its own with such high costs of innovation. In the case of drugs, they are the highest.

 

Panelists discussing at the conference organized by CEZAMAT Warsaw University of Technology pointed to the development of the domestic pharmaceutical sector – Poland is one of Europe’s leading producers of generics, i.e. generic drugs – said Marcin Czech, president of the Polish Pharmacoeconomic Society. – The creation of “second generation” drugs requires many years of work, and we go from generics through micro-innovations, production of biosequence drugs to innovative drugs, which I believe will appear soon – he said.

During the “Innovations for Health” conference, the activities of the NTMed cluster of New Medical Technologies were initiated. The cluster will support technology transfer in the field of medicine and pharmacy. CEZAMAT PW concluded agreements with entities operating in the sector of medical devices and medicinal products. Among them are:

ZAKŁADY FARMACEUTYCZNE „POLPHARMA” S.A. – signed the agreement on behalf of the Management Board by dr Monika Lamparska-Przybysz,

POLSKI ZWIĄZEK PRACODAWCÓW PRZEMYSŁU FARMACEUTYCZNEGO – KRAJOWI PRODUCENCI LEKÓW – the agreement was signed by the President of the Management Board Krzysztof Kopeć,

POLSKI ZWIĄZEK INNOWACYJNYCH FIRM BIOTECHNOLOGII MEDYCZNEJ BIOINMED – the agreement was signed by the President of the Management Board Marta Winiarska,

OGÓLNOPOLSKA IZBA GOSPODARCZA WYROBÓW MEDYCZNYCH „POLMED” – the agreement was signed by the President of the Chamber Arkadiusz Grądkowski,

EZRA UKSW SPÓŁKA Z O.O. – the agreement was signed by the President of the Management Board Tomasza Rowińskiego,

OLYMPUS POLSKA SPÓŁKA Z O.O. – the agreement for signature on behalf of the Management Board Edyta Czapska-Koprowska,

Przemysław Furdal i Grzegorz Suwalski signed contracts for four companies:
HEART SENSE SPÓŁKA Z O.O.
QUANTUM INNOVATIONS SPÓŁKA Z O.O.
HEART GUARD SPÓŁKA Z O. O.
CORFLOW SPÓŁKA Z O.O.

MEDINICE S.A. – on behalf of the Management Board, the agreement was presented for signature by Michał Sosnowski,

SCREENMED SPÓŁKA Z O.O. – the agreement was signed by the President of the Management Board Magdalena Nowińska,

DRAMIŃSKI S.A. – presented the agreement for signature on behalf of the Management Board Włodzimierz Roguski,

NIVALIT SPÓŁKA Z O.O. – the agreement was signed by the Vice-President of the Management Board Wojciech Komnata,

SCIENCE4BEAUTY SPÓŁKA Z O.O. – signed by the President dr Anna Mazurkiewicz-Pisarek and Member of the Management Board dr Alina Mazurkiewicz.

The newly established NTMed Cluster, as indicated by Aleksandra Mościcka-Studzińska, Deputy Director of CEZAMAT WUT, has the ambition to support the development of innovativeness of the Polish sector of medical devices and medicinal products through constant dialogue with representatives of this industry and scientific bodies in order to share new solutions and technologies, as well as to be a platform undertaking joint activities and implementing joint projects for the effective use of the potential of the associated entities.

Contact:
Aleksandra Mościcka-Studzińska
aleksandra.studzinska@pw.edu.pl

 

The “Innovation for Health” conference was carried out as part of the Innovation Hub project at the CEZAMAT Center for Advanced Materials and Technology of the Warsaw University of Technology as part of the “Science for Society” program of the Ministry of Education and Science.